The goal of Molecular Diagnostics, also known as the detection of genomic variants, is to make it easier to detect, diagnose, classify, predict outcomes, and monitor therapeutic response. The field of molecular diagnostics is the result of the successful interaction between laboratory medicine, genomics knowledge, and technology, particularly in light of significant advancements in molecular genomic technologies.
The process of Molecular Diagnostics, also known as molecular pathology, is collecting DNA or RNA, the distinctive genetic code contained in each of our cells, and examining the sequences for warning signs that may indicate the onset of a particular disease. In recent years, the field has grown significantly. Molecular assays created for diagnostic application can either identify specific protein signatures, like MALDI-ToF, or detect targeted genetic material, like nucleic acids. A nucleic acid amplification test (NAAT) is a sort of molecular test that amplifies a particular nucleic acid sequence using the polymerase chain reaction (PCR) or a related technology (such as deep sequencing, NASBA, etc.). PCR is a chemical reaction that exponentially amplifies the targeted nucleic acid to detectable levels and is catalysed by fast temperature cycling. The amount of genetic material in the beginning sample is doubled after one PCR cycle. Millions to billions of copies are produced by doing several PCR cycles. Even if the targeted nucleic acid is present in very minute quantities in the patient sample, a molecular PCR test can still detect it. In laboratory medicine, NAATs have a wide range of beneficial uses, including the diagnosis of infectious diseases, cancer, and genetics. An oncologist, for instance, might employ molecular nucleic acid testing to help customise cancer treatment depending on the precise genetic mutations found in a patient's tumour. Similar to this, a physician specialising in infectious diseases may utilise an NAAT to quickly ascertain the pathogenic origin of an illness and locate genetic markers that might denote drug resistance, assisting them in optimising therapy. Additionally, chromosomal abnormalities or modifications that may increase a patient's chance of contracting a specific disease or ailment can be found via a molecular test. In comparison to conventional standard of care methods, such as culture, a NAAT can offer laboratories crucial improvements in accuracy and speed when it comes to the diagnosis of infectious diseases. In turn, Molecular Diagnostics solutions used in laboratories help healthcare professionals get the answers they require more quickly to improve treatment. The organism is often grown in culture during traditional testing, which can be challenging and time-consuming and necessitates that the organism in the patient sample be viable. There are frequently no accurate diagnostic tests for viral infections. Additionally, a lot of frequently utilised tests don't focus on all the possible sources of an infection in a patient, which necessitates additional testing and invasive treatments. Deoxyribonucleic acid (DNA) or ribonucleic acid (RNA) specific sequence disturbances that may be linked to disease are found using Molecular Diagnostics procedures. Multiple diseases are caused by the disruption of single nucleotide polymorphisms (SNPs), deletions, rearrangements, insertions, and other causes. Sexually transmitted diseases, cancer, oncology, and infectious diseases all call for the use of molecular diagnostic tests. Due to molecular diagnostics' ability to identify specific diseases, patients can benefit from precision medicine.
0 Comments
Leave a Reply. |
Categories
All
|